Djavan B - Search Results

1

Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.

Eckersberger E, Finkelstein J, Sadri H, Margreiter M, Taneja SS, Lepor H, Djavan B. Eckersberger E, et al. Among authors: djavan b. Rev Urol. 2009 Summer;11(3):127-33. Rev Urol. 2009. PMID: 19918338 Free PMC article.

2

Biopsy standards for detection of prostate cancer.

Djavan B, Margreiter M. Djavan B, et al. World J Urol. 2007 Mar;25(1):11-7. doi: 10.1007/s00345-007-0151-1. Epub 2007 Mar 7. World J Urol. 2007. PMID: 17342490 Review.

3

Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience.

Finkelstein J, Eckersberger E, Sadri H, Taneja SS, Lepor H, Djavan B. Finkelstein J, et al. Among authors: djavan b. Rev Urol. 2010 Winter;12(1):35-43. Rev Urol. 2010. PMID: 20428292 Free PMC article.

4

Prostate-specific antigen testing and prostate cancer screening.

Djavan B, Eckersberger E, Finkelstein J, Sadri H, Taneja SS, Lepor H. Djavan B, et al. Prim Care. 2010 Sep;37(3):441-59, vii. doi: 10.1016/j.pop.2010.05.001. Prim Care. 2010. PMID: 20705192 Review.

5

Uro-oncological controversies in euro-oncology: highlights from the European association of urology section of oncological urology, january 15-17, 2010, vienna, austria.

Eckersberger E, Lepor H, Sadri H, Farr A, Margreiter M, Harik M, Djavan B. Eckersberger E, et al. Among authors: djavan b. Rev Urol. 2010 Spring;12(2-3):e125-8. Rev Urol. 2010. PMID: 20811549 Free PMC article. No abstract available.

6

Gene polymorphisms and prostate cancer: the evidence.

Dianat SS, Margreiter M, Eckersberger E, Finkelstein J, Kuehas F, Herwig R, Ayati M, Lepor H, Djavan B. Dianat SS, et al. Among authors: djavan b. BJU Int. 2009 Dec;104(11):1560-72. doi: 10.1111/j.1464-410X.2009.08973.x. BJU Int. 2009. PMID: 20053187 Review.

7

Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.

Djavan B, Eckersberger E, Handl MJ, Brandner R, Sadri H, Lepor H. Djavan B, et al. Can J Urol. 2010 Aug;17(4):5249-54. Can J Urol. 2010. PMID: 20735902 Review.

8

Analysis of testosterone suppression in men receiving histrelin, a novel GnRH agonist for the treatment of prostate cancer.

Djavan B, Schlegel P, Salomon G, Eckersberger E, Sadri H, Graefen M. Djavan B, et al. Can J Urol. 2010 Aug;17(4):5265-71. Can J Urol. 2010. PMID: 20735905

9

An algorithm for medical management in male lower urinary tract symptoms.

Djavan B, Margreiter M, Dianat SS. Djavan B, et al. Curr Opin Urol. 2011 Jan;21(1):5-12. doi: 10.1097/MOU.0b013e32834100ef. Curr Opin Urol. 2011. PMID: 21045704 Review.

10

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer.

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H. Djavan B, et al. BJU Int. 2011 Nov;108(10):1582-7. doi: 10.1111/j.1464-410X.2011.10173.x. Epub 2011 Mar 28. BJU Int. 2011. PMID: 21443653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page